4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000030
Chief Executive Officer sold 15,439 shares at $20.86 ($322,058)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salzmann Peter Chief Executive Officer | 2025-02-19 | Sale | −15,439 | $20.86 | $322,058 | 948,786 | D |
| Open-market sales · 15,439 sh · avg $20.86 · $322,058 | |||||||
Loading xslF345X05/wk-form4_1740171852.xml…